Recombinant DNA (rDNA) Technology - Global Market Outlook (2017-2023)

Recombinant DNA (rDNA) Technology - Global Market Outlook (2017-2023)

  • Published: October 2017
  • ID: SMRC16790

The Global Recombinant DNA (rDNA) Technology Market is accounted for $499.8 million in 2016 and expected to grow at a CAGR of 6.9% to reach $799.9 million by 2023. Factors influencing the market growth are rise in Genetically Modified (GM) crop, development of biofuel and biopesticides, presence of biopharmaceuticals pipeline and production of various therapeutic proteins. Lack of government funding for research and development in emerging economies, risks involved in usage of genetically modified food and regulatory & ethical challenges associated with gene therapy are hampering the market growth.

Based on component, the Expression systems are used for the production of protein from recombinant DNA molecules. Majorly used expression systems are mammalian, bacterial, insects, and yeast. Development of cell lines such as HEK293 and Chinese Hamster Ovarian (CHO) has contributed to the significant share of mammalian expression system. Further, , ongoing research to explore the prospective of plant as expression system are expected to underpin the adoption of plans expression system for Genetically Modified product development in the future. Furthermore, more than 3000 scientific studies have been carried out to assess the GM products safety in context to its impact on human health and environment.

Based on application, Agricultural plants are one of the most frequently cited cases of genetically modified organisms. Some benefits of genetic engineering in agriculture are increased crop yields, reduces cost for food or drug production, limited need for pesticides, enhanced nutrient composition and food quality, resistance to pests and disease, with enormous food security, and medical benefits. The advantage of recombinant DNA technology is that new combinations of genes are determined in the forefront. GE has also been used against crop pathogens. One of the first and most successful genetically modified crops was a papaya with resistance to ringspot virus. Another example includes the development of bananas resistant to wilt in Uganda.

North America accounted for the maximum share of the market which attributes to a affluent number of biopharmaceutical manufacturing companies are situated in the U.S. In July 2017, U.S witnessed the 1st FDA approval for gene therapy treatment. The treatment was developed for leukemia disorder, in conjugation between the University of Pennsylvania and Novartis Corp. This, in turn, furtherance the enact of rDNA techniques in the region. Asia Pacific is expected to be the fastest growing market. Clinical trials in Asian countries such as India and China are less expensive compared to other regions which made migration of several biopharmaceutical developers towards this region.

Some of the key players in Global Recombinant DNA (rDNA) Technology market are F. Hoffmann-La Roche Ltd, Monsanto Company, Amgen Inc, Biocon, Biogen, Eli Lilly and Company, GenScript, GlaxoSmithKline plc, Horizon Discovery Group PLC, Merck & Co, New England Biolabs., Novartis AG, Novo Nordisk A/S, Pfizer Inc and Profacgen.

Components Covered:
• Cloning Vector
• Expression System

Products Covered:

• Non-medical
• Medical

Applications Covered:

• Health & Disease
• Food & Agriculture
• Environment
• Other Applications

End Users Covered:
• Academic & Research Institutes
• Pharmaceutical & Biotech Entities
• Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary          
            
2 Preface 
         
 2.1 Abstract          
 2.2 Stake Holders         
 2.3 Research Scope         
 2.4 Research Methodology        
  2.4.1 Data Mining        
  2.4.2 Data Analysis        
  2.4.3 Data Validation        
  2.4.4 Research Approach        
 2.5 Research Sources         
  2.5.1 Primary Research Sources       
  2.5.2 Secondary Research Sources       
  2.5.3 Assumptions        
            
3 Market Trend Analysis         
 3.1 Introduction         
 3.2 Drivers          
 3.3 Restraints         
 3.4 Opportunities         
 3.5 Threats          
 3.6 Product Analysis         
 3.7 Application Analysis        
 3.8 End User Analysis         
 3.9 Emerging Markets         
 3.10 Futuristic Market Scenario        
            
4 Porters Five Force Analysis         
 4.1 Bargaining power of suppliers        
 4.2 Bargaining power of buyers        
 4.3 Threat of substitutes        
 4.4 Threat of new entrants        
 4.5 Competitive rivalry         
            
5 Global Recombinant DNA (rDNA) Technology Market, By Component     
 5.1 Introduction         
 5.2 Cloning Vector         
  5.2.1 Phage         
  5.2.2 Bacterial Artificial Chromosome (BAC)      
  5.2.3 Human Artificial Chromosome (HAC)      
  5.2.4 Yeast Artificial Chromosome (YAC)      
  5.2.5 Cosmid         
  5.2.6 Plasmid         
 5.3 Expression System         
  5.3.1 Baculovirus/Insect        
  5.3.2 Bacteria         
  5.3.3 Mammalian        
  5.3.4 Yeast         
  5.3.5 Other Expression System       
            
6 Global Recombinant DNA (rDNA) Technology Market, By Product     
 6.1 Introduction         
 6.2 Non-medical         
  6.2.1 Specialty Chemicals        
  6.2.2 Biotech Crops        
  6.2.3 Other Non-Medical Technology      
 6.3 Medical          
  6.3.1 Human Protein        
  6.3.2 Therapeutic Agent        
  6.3.3 Vaccine         
            
7 Global Recombinant DNA (rDNA) Technology Market, By  Application      
 7.1 Introduction         
 7.2 Health & Disease         
  7.2.1 Human         
    7.2.2 Animal         
 7.3 Food & Agriculture         
 7.4 Environment         
 7.5 Other Applications         
            
8 Global Recombinant DNA (rDNA) Technology Market, By End User      
 8.1 Introduction         
 8.2 Academic & Research Institutes       
 8.3 Pharmaceutical & Biotech Entities       
 8.4 Other End Users         
            
9 Global Recombinant DNA (rDNA) Technology Market, By Geography     
 9.1 Introduction         
 9.2 North America         
  9.2.1 US         
  9.2.2 Canada         
  9.2.3 Mexico         
 9.3 Europe          
  9.3.1 Germany         
  9.3.2 U.K         
  9.3.3 France         
  9.3.4 Italy         
  9.3.5 Spain         
  9.3.6 Rest of Europe        
 9.4 Asia Pacific         
  9.4.1 Japan         
  9.4.2 China         
  9.4.3 India         
  9.4.4 Australia         
  9.4.5 New Zealand        
  9.4.6 South Korea        
  9.4.7 Rest of Asia Pacific        
 9.5 South America         
  9.5.1 Argentina        
  9.5.2 Brazil         
  9.5.3 Chile         
  9.5.4 Rest of South America       
 9.6 Middle East & Africa        
  9.6.1 Saudi Arabia        
  9.6.2 UAE         
  9.6.3 Qatar         
  9.6.4 South Africa        
  9.6.5 Rest of Middle East & Africa       
            
10 Key Developments          
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures     
 10.2 Acquisitions & Mergers        
 10.3 New Product Launch        
 10.4 Expansions         
 10.5 Other Key Strategies        
            
11 Company Profiling          
 11.1 F. Hoffmann-La Roche Ltd        
 11.2 Monsanto Company         
 11.3 Amgen Inc         
 11.4 Biocon          
 11.5 Biogen          
 11.6 Eli Lilly and Company        
 11.7 GenScript         
 11.8 GlaxoSmithKline plc        
 11.9 Horizon Discovery Group PLC        
 11.10 Merck & Co         
 11.11 New England Biolabs.        
 11.12 Novartis AG         
 11.13 Novo Nordisk A/S         
 11.14 Pfizer Inc          
 11.15 Profacgen         


List of Tables           
1 Global Recombinant DNA (rDNA) Technology Market Outlook, By Region (2014-2023) ($MN)   
2 Global Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)  
3 Global Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)  
4 Global Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
5 Global Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
6 Global Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
7 Global Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)   
8 Global Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)   
9 Global Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)  
10 Global Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)  
11 Global Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)   
12 Global Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)  
13 Global Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)   
14 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN) 
15 Global Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)   
16 Global Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)  
17 Global Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN) 
18 Global Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)  
19 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
20 Global Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)   
21 Global Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)  
22 Global Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)  
23 Global Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)   
24 Global Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)  
25 Global Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)  
26 Global Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)   
27 Global Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)   
28 Global Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)  
29 Global Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)  
30 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)  
31 Global Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)   
32 Global Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
33 Global Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
34 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)  
35 North America Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)  
36 North America Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN) 
37 North America Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN) 
38 North America Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
39 North America Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
40 North America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
41 North America Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)  
42 North America Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)  
43 North America Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN) 
44 North America Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN) 
45 North America Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)  
46 North America Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN) 
47 North America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)  
48 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
49 North America Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)  
50 North America Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN) 
51 North America Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN) 
52 North America Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN) 
53 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
54 North America Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)  
55 North America Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN) 
56 North America Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN) 
57 North America Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)  
58 North America Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN) 
59 North America Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN) 
60 North America Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)  
61 North America Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)  
62 North America Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN) 
63 North America Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN) 
64 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN) 
65 North America Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)  
66 North America Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
67 North America Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
68 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN) 
69 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)   
70 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)  
71 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)  
72 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
73 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
74 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
75 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)   
76 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)   
77 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN) 
78 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)  
79 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)   
80 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)  
81 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)   
82 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN) 
83 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)   
84 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)  
85 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN) 
86 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)  
87 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
88 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)   
89 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)  
90 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)  
91 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)   
92 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)  
93 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)  
94 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)   
95 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)   
96 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN) 
97 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)  
98 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN) 
99 Europe Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)  
100 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
101 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
102 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)  
103 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)  
104 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)  
105 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN) 
106 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
107 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
108 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
109 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)  
110 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)  
111 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN) 
112 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN) 
113 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)  
114 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)  
115 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)  
116 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN) 
117 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)  
118 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)  
119 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN) 
120 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)  
121 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
122 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)  
123 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN) 
124 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN) 
125 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)  
126 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)  
127 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN) 
128 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)  
129 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)  
130 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN) 
131 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)  
132 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN) 
133 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)  
134 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
135 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
136 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN) 
137 South America Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)  
138 South America Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN) 
139 South America Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN) 
140 South America Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
141 South America Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
142 South America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
143 South America Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)  
144 South America Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)  
145 South America Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN) 
146 South America Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN) 
147 South America Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)  
148 South America Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN) 
149 South America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)  
150 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
151 South America Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)  
152 South America Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN) 
153 South America Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN) 
154 South America Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN) 
155 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
156 South America Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)  
157 South America Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN) 
158 South America Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN) 
159 South America Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)  
160 South America Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN) 
161 South America Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN) 
162 South America Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)  
163 South America Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)  
164 South America Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN) 
165 South America Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN) 
166 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN) 
167 South America Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)  
168 South America Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
169 South America Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
170 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN) 
171 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN) 
172 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN) 
173 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN) 
174 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
175 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
176 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
177 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN) 
178 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN) 
179 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
180 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
181 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN) 
182 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN) 
183 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)  
184 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
185 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN) 
186 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN) 
187 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
188 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN) 
189 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
190 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN) 
191 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN) 
192 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
193 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN) 
194 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN) 
195 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
196 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN) 
197 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN) 
198 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
199 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN) 
200 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
201 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN) 
202 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
203 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
204 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)

 

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials